The expected annual net loss attributable to shareholders of SKL (00974) is approximately 11.5 million to approximately 17.5 million yuan.

19:20 12/03/2026

China Shunkelong (00974) announced that it is expected to incur a net loss attributable to the owners of the company of approximately RMB 11.5 million to RMB 17.5 million for the year ending December 31, 2025. The net loss attributable to the owners of the company in the same period in 2024 was approximately RMB 67.976 million.

SKL (00974) announces that the expected net loss attributable to the owners of the company for the year ending December 31, 2025 is expected to be approximately RMB 11.5 million to RMB 17.5 million. The net loss attributable to the owners of the company for the same period in 2024 was approximately RMB 67.976 million.

GF Healthcare (08143) plans to conduct a stock merger.

PW MEDTECH (01358): voluntarily terminates Sichuan Rejian Medical from listing on the Beijing Stock Exchange.

New Stock News | Reports say that Legend Biotech Corp. Sponsored ADR (LEGN.US) plans to list in Hong Kong this year and raise $300 to $400 million.

GF Healthcare (08143) plans to conduct a stock merger.

PW MEDTECH (01358): voluntarily terminates Sichuan Rejian Medical from listing on the Beijing Stock Exchange.

New Stock News | Reports say that Legend Biotech Corp. Sponsored ADR (LEGN.US) plans to list in Hong Kong this year and raise $300 to $400 million.